Molecule Structure

Scientific Name

Goserelin

Description of the Drug

Goserelin is a synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00014

Brand Name(s)

Zoladex

Company Owner(s)

Tersera Therapeutics Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Gonadotropin-releasing hormone receptor SINGLE PROTEIN AGONIST CHEMBL1855

Unichem Links

SureChEMBL SCHEMBL19712239 SCHEMBL20459194 SCHEMBL8643
Human Metabolome Database HMDB0014259
DrugBank DB00014
PubChem: Thomson Pharma 14841899
PubChem 5311128
LINCS LSM-46023
Nikkaji J34.701I
EPA CompTox Dashboard DTXSID7048297
DrugCentral 1327
Guide to Pharmacology 3879
rxnorm GOSERELIN GOSERELIN ACETATE ZOLADEX
PubChem: Drugs of the Future 12012688
ChEBI 5523